Transforming Medical Communications

The episode delivers solid, actionable insights about localization and audience-centric medical communications. Key concepts like the gap between global scientific completeness and local physician needs, modular communication design, and the three components of 'so what' (patient journey, access, follow-up) are substantive. However, there is considerable repetition of themes, modest padding with explanatory throat-clearing, and the core insight - that one-size-fits-all global communication fails in diverse healthcare systems - is not particularly novel in 2024. The episode would benefit from more concrete implementation metrics or failure case studies.

“Global often focuses on comprehensive scientific completeness. Right. So we want to make sure that we are not deviating from evidence based. Right. So when we are developing any communication, while local physicians need something concise, something that is practical guidance that they can apply within their healthcare constraints”

“we need to really pause and then think about uh, continuous local insights, get input into what we are developing globally. And uh, we don't do that very often.”

The framing of 'global with local' (not 'global to local') and the emphasis on the 'so what' as a distinct strategic layer show thoughtful reframing, but these concepts are not contrarian or truly novel. The Doctors Without Borders anthropologist example is compelling and illustrates a principle well, but localization, patient-centricity, and modular design are well-established best practices in medical communications and broader industries. The AI and 'clip economy' references feel somewhat surface-level and borrowed from adjacent discussions rather than original to this guest.

“First of all, we call it global with local. Now that is not global too local. So it's a big difference between these two wording. Right?”

“The scientific narrative should be clear right from the beginning, from below perspective, but it should be very simple. Right? So scientific narrative is talking about what's the disease state. Definition is, uh, then what's the treatment and diagnosis paradigm looks like for that disease. And then the most important piece that is most of the time is missing is the so what?”

Babak Abased is a highly credible guest with genuine operating experience: 20+ years spanning emergency medicine, global medical affairs, commercial leadership, and international market strategy, currently VP of Global Medical Affairs at Amgen. His volunteer work with Doctors Without Borders in remote settings (Ethiopia, tuberculosis protocols) demonstrates hands-on field exposure beyond typical corporate practice. He has clearly navigated real localization challenges across geographies and business functions. This is a substantive practitioner, not a consultant or theorist, though the conversation itself could have pushed him harder on execution constraints.

“he is the Vice President of Global Medical general medicine at Ah Amgen. He brings also more than 20 years of medical and pharmaceutical experience spanning emergency medicine, global medical affairs, commercial leadership, and also international market strategy.”

“when I was working with Doctors Without Borders, they send us to very remote areas to provide care for patients. So in one of our missions they send us to provide care for a uh, nomadic population in Ethiopia.”

The episode includes several specific examples: the India hypertension project (millions in remote areas, no LDL testing infrastructure), Mexico's three different hospital patient journeys within one city, Canada/Quebec hospital access variation for cancer therapy, Ethiopia nomadic TB treatment protocol adaptation, China patient advisory boards influencing clinical study design, and a clinical trial recruitment failure due to two-day caregiver burden. However, these examples lack hard data: no patient numbers, efficacy metrics, adherence rates, or ROI comparisons. The ACC rap-format guideline is mentioned but not quantified. The episode would be stronger with specific baseline vs. post-adaptation metrics or concrete conversion/engagement numbers.

“they implemented a very large project in remote areas in India in treating hypertension. So their project cover millions of people in a remote areas in India uh, by providing free antihypertensive medication”

“there was three different model of the patient care within the same city of uh, Mexico City, right. So there was a patient care that they go through private hospitals, patient care that they go through public hospitals, and a patient care that they go through government based hospitals”

The host (Speaker C) demonstrates reasonable preparation and asks coherent follow-ups, particularly around the gap between headquarters and local needs, the spectrum of complexity (academics vs. community oncologists), and resource constraints of small affiliates. However, questioning is generally soft and affirmative - the host frequently validates the guest's points rather than challenging assumptions or pressing on contradictions. When the guest claims 'mindset shift' and AI as solutions, the host does not interrogate feasibility, cost, or failure modes. The host's own anecdotes about his boss rejecting local research (20 years ago) take up time without being used to stress-test the guest's current recommendations. The conversation lacks productive tension or genuine disagreement.

“So where is the breakdown so we”

“So what would you say is the biggest gap between then how headquarters, like you mentioned it, is designing scientific communications and what physicians actually need in practice?”